Ethical justification of single-blind and double-blind placebo-controlled response tests in neuropathic pain and N-of-1 treatment paradigm in clinical settings

Jan M Keppel Hesselink1 Institute for Neuropathic Pain, Bosch en Duin, The Netherlands, [email protected]Correspondence[email protected]

David J Kopsky2 Institute for Neuropathic Pain, Amsterdam, The Netherlands

Arun K Bhaskar3 Pain Management Centre, Charing Cross Hospital Imperial Healthcare NHS Trust, London, UK

Pages 345-352 | Published online: 14 Jan 2019

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

References

van HeckeOAustinSKKhanRASmithBHTorranceNNeuropathic pain in the general population: a systematic review of epidemiological studiesPain2014155465466224291734
PubMed Web of Science ®Google Scholar
PérezCRiberaMVGálvezRHigh prevalence of confirmed, but also of potential and believed, neuropathic pain in pain clinicsEur J Pain201317334735622927200
PubMed Web of Science ®Google Scholar
JacovidesABogoshiMDistillerLAAn epidemiological study to assess the prevalence of diabetic peripheral neuropathic pain among adults with diabetes attending private and institutional outpatient clinics in South AfricaJ Int Med Res20144241018102824891556
PubMed Web of Science ®Google Scholar
AbbottCAMalikRAvan RossERKulkarniJBoultonAJPrevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the UKDiabetes Care201134102220222421852677
PubMed Web of Science ®Google Scholar
RubleJOff-label prescribing of medications for pain: maintaining optimal care at an intersection of law, public policy, and ethicsJ Pain Palliat Care Pharmacother201226214615222764854
PubMedGoogle Scholar
LangedijkJContinuous Innovation in the Drug Life CyclePatient Needs and the Marketing Authorization for Medicinal Products: An Analysis of EU Law Chapter 4.1UtrechtUtrecht University2016
Google Scholar
KopskyDKeppel HesselinkJPhenytoin cream for the treatment for neuropathic pain: case seriesPharmaceuticals201811253
Web of Science ®Google Scholar
VavraMWRubinDIThe peripheral neuropathy evaluation in an office-based neurology settingSemin Neurol201131110211421321837
PubMed Web of Science ®Google Scholar
EMAGuideline on clinical medical products intended for the treatment of neuropathic painLondonEMA2007 Available from: https://www.ema.europa.eu/documents/scientific-guideline/guideline-clinical-medicinal-products-intended-treatment-neuropathic-pain_en.pdfAccessed January 7, 2019
Google Scholar
FarrarJTYoungJPLamoreauxLWerthJLPooleMRClinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scalePain200194214915811690728
PubMed Web of Science ®Google Scholar
TouwenDPEngbertsDPThose famous red pills – deliberations and hesitations. Ethics of placebo use in therapeutic and research settingsEur Neuropsychopharmacol2012221177578122534614
PubMed Web of Science ®Google Scholar
FässlerMMeissnerKSchneiderALindeKFrequency and circumstances of placebo use in clinical practice – a systematic review of empirical studiesBMC Med20108117417015
Web of Science ®Google Scholar
FinnissDGKaptchukTJMillerFBenedettiFBiological, clinical, and ethical advances of placebo effectsLancet2010375971568669520171404
PubMed Web of Science ®Google Scholar
LichtenbergPHeresco-LevyUNitzanUThe ethics of the placebo in clinical practiceJ Med Ethics200430655155415574442
PubMed Web of Science ®Google Scholar
ArnoldMHFinnissDGKerridgeIMedicine’s inconvenient truth: the placebo and nocebo effectIntern Med J201444439840524754688
PubMed Web of Science ®Google Scholar
GuyattGSackettDAdachiJA clinician’s guide for conducting randomized trials in individual patientsCMAJ198813964975033409138
PubMed Web of Science ®Google Scholar
MirzaRDPunjaSVohraSGuyattGThe history and development of N-of-1 trialsJ R Soc Med2017110833034028776473
PubMed Web of Science ®Google Scholar
LillieEOPatayBDiamantJIssellBTopolEJSchorkNJThe n-of-1 clinical trial: the ultimate strategy for individualizing medicine?Per Med20118216117321695041
PubMed Web of Science ®Google Scholar
GuyattGHHeytingAJaeschkeRKellerJAdachiJDRobertsRSN of 1 randomized trials for investigating new drugsControl Clin Trials1990112881002161315
PubMedGoogle Scholar
PunjaSSchmidCHHartlingLUrichukLNiklesCJVohraSTo meta-analyze or not to meta-analyze? A combined meta-analysis of N-of-1 trial data with RCT data on amphetamines and methylphenidate for pediatric ADHDJ Clin Epidemiol201676768127060386
PubMed Web of Science ®Google Scholar
BarskyAJSaintfortRRogersMPBorusJFNonspecific medication side effects and the nocebo phenomenonJAMA2002287562262711829702
PubMed Web of Science ®Google Scholar
DworkinRHTurkDCPeirce-SandnerSConsiderations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendationsPain201215361148115822494920
PubMed Web of Science ®Google Scholar
Keppel HesselinkJMKopskyDJThe individualized N-of-1 trial: dose-response in a single-blind cross-over response test of phenytoin 10% and 30% cream in neuropathic painEC Anaesthesia20184616
Google Scholar
BostickNASadeRLevineMAStewartDMAmerican Medical Association Council on Ethical and Judicial AffairsPlacebo use in clinical practice: report of the American Medical Association Council on Ethical and Judicial AffairsJ Clin Ethics2008191586118552054
PubMedGoogle Scholar
Panel tDMCN-o-GDesign and Implementation of N-of-1 Trials: A User’s GuideKravitzRLDuanNRockville, MDAgency for Healthcare Research and Quality AHRQ Publication13(14)-EHC122-EF;2014
Google Scholar

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Ethical justification of single-blind and double-blind placebo-controlled response tests in neuropathic pain and N-of-1 treatment paradigm in clinical settings

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Ethical justification of single-blind and double-blind placebo-controlled response tests in neuropathic pain and N-of-1 treatment paradigm in clinical settings

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date